Leave Your Message
Wholesale Nitroxoline (5-Nitro-8-Quinolinol) CAS 4008-48-4 - China Suppliers & Factory with COA & SDS Available
Hot Products

Wholesale Nitroxoline (5-Nitro-8-Quinolinol) CAS 4008-48-4 - China Suppliers & Factory with COA & SDS Available

Nitroxoline, also known as 5-nitroquinolin-8-ol, is a powerful urinary antibacterial agent specifically designed to combat infections caused by both gram-positive and gram-negative bacteria commonly found in urinary tract infections. As a trusted supplier of Nitroxoline in China, our factory ensures the highest quality standards in production. This essential medication is effective in treating various urinary infections, making it a preferred choice among healthcare professionals. Choose our reliable China suppliers for your Nitroxoline needs and benefit from our commitment to quality and excellence

    Product Parameters
    Product Name Nitroxoline
    CAS NO 4008-48-4
    Structure Nitroquinoline Structure
    Molecular formula C9H6N2O3
    Purity Over 99.5%
    Other product names 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, 5-nitroquinolin-8-ol
    Molecular weight 190.16
    In Vitro Activity
    Using spectrophotometric fluorescence assay, Nitroxoline can significantly reduce the degradation of extracellular DQ collagen IV in all tested cancer cell lines. Nitroxoline can significantly reduce real-time monitoring of tumor cell invasion and decrease the invasive growth of multicellular tumor spheroids, which can be used as a three-dimensional vitreous model of tumor invasion. In vitro angiogenesis experiments, Nitroxoline can significantly reduce the formation of endothelial tubes.
    In Vivo Activity
    Nitroxoline significantly inhibited tumor growth, angiogenesis and metastasis in LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.
    Kinase Experiment
    In Vitro Kinase Assays: The potency of SP600125 towards kinases, including MPS1, JNK, and Aurora kinase A, is determined based on the specific measurement of radioactive phosphotransfer to the substrate. For each enzyme, the absolute Km values for ATP and the specific substrate are initially determined and each assay is then run at optimized [ATP] (2·αKm) and [substrate] (5·Km) concentrations. MPS1 activity is measured using 5 nM of MPS1 recombinant protein in 50 mM HEPES pH 7.5, 2.5 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 3 μM NaVO3, 2 mM β-glycerophosphate, 0.2 mg/mL BSA, 200 μM P38-βtide substrate-peptide (KRQADEEMTGYVATRWYRAE), and 8 μM ATP with 1.5 nM 33P-γ-ATP. Ten serial 1:3 dilutions (from 30 μM to 1.5 nM) of SP600125 are tested and IC50 determined.
    Cell Experiment
    Cell suspension are seeded in the wells of an E-plate 16 according to the manufacturer's instructions. After seeding, the CI is monitored every 15 min. After ∼10 h (MCF-10A neoT and MMTV-PyMT), 14 h (U-87 MG) or 24 h (LPB), when the cells are in their log phase of growth, 50 μl of the compound or 0.1% DMSO is added, and the experiment allowed to run for 72 h. Once every 24 h the medium is replaced with fresh medium containing the inhibitor or suitable control to prevent cell death due to medium depletion. Compounds and their concentrations are: nitroxoline (5 μM) and CA-074 (5 μM) for all cell lines other than MCF-10A neoT cell line, where nitroxoline was used at 2.5 μM. All measurements were performed in quadruplicate. (Only for Reference)
    Frequently Asked Questions (FAQ)
    Q: What is the CAS number and molecular weight of Nitroxoline?
    Nitroxoline has a CAS number of 4008-48-4 and a molecular weight of 190.16.
    Q: What are the alternative names for Nitroxoline?
    It is also known as 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, and 5-nitroquinolin-8-ol.
    Q: How does Nitroxoline perform in in vitro activity assays?
    In vitro, Nitroxoline significantly reduces the degradation of extracellular DQ collagen IV in tested cancer cell lines, decreases the invasive growth of multicellular tumor spheroids, and reduces endothelial tube formation during angiogenesis.
    Q: What effects does Nitroxoline show in vivo?
    In vivo studies show that Nitroxoline significantly inhibits tumor growth, angiogenesis, and metastasis in both LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.
    Q: What are the recommended concentrations of Nitroxoline for cell experiments?
    In cell experiments, Nitroxoline is typically used at a concentration of 5 μM for most cell lines, except for the MCF-10A neoT cell line, where it is applied at 2.5 μM.